HEALTHJun 29 · 03:00 UTCSCMP WORLDJulie Zhang

China’s first AI-powered cancer vaccine production line set to launch in Beijing

China is launching its first AI-powered production line for personalized cancer vaccines, developed by Beijing-based Likang Life Sciences. The company plans to complete a new drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October, with a 110 million yuan investment.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

ChinaplaceLikang Life SciencesorganizationBeijing Economic and Technological Development ZoneplaceAI-assisted personalised tumour vaccinestopiccancertopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 29 · 03:00 UTC
China’s first AI-powered cancer vaccine production line set to launch in Beijing
HEALTHJun 1 · 07:02 UTC
Akeso To Boost Manufacturing Of Cancer Drug
HEALTHJun 14 · 10:00 UTC
London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
SCIENCEApr 2 · 08:27 UTC
Scientists create “smart” DNA drug that targets cancer cells with extreme precision
HEALTHJun 1 · 18:48 UTC
Moderna gets $50M investment for Ebola vaccine candidate
BUSINESSMay 26 · 11:29 UTC
STAT+: Eli Lilly to buy three small vaccine developers